| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-14 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-13 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-13 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-13 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-12 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-12 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.33 | 2e-11 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.31 | 3e-11 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-11 |